1167 — Jacobio Pharmaceuticals Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual income statement for Jacobio Pharmaceuticals Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	486	153	95.7	63.5	156
Cost of Revenue
Gross Profit	442	12.8	12.6	3.2	156
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	307	472	490	461	344
Operating Profit	179	-319	-394	-398	-188
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-1,514	-301	-372	-359	-156
Provision for Income Taxes
Net Income After Taxes	-1,514	-301	-372	-359	-156
Minority Interest
Net Income Before Extraordinary Items
Net Income	-1,514	-301	-372	-359	-156
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-1,514	-301	-372	-359	-156
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-1.96	-0.403	-0.495	-0.465	-0.196